Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6) Peptide
SSX6
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN939479
Aperçu rapide pour Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6) Peptide (ABIN939479)
Antigène
SSX6
(Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- IPKIMPEKPA EEGSDSKGVP EASGPQNDGK KLCPPGKASS SEKIHERSGP
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSX6 antibody,
Alternative Names: SSX6 control peptide, SSX6 antibody Blocking Peptide, Anti-SSX6 Blocking Peptide, synovial sarcoma, X breakpoint 6 Blocking Peptide, dJ54B20.1 Blocking Peptide, SSX6, SSX-6, SSX 6, SSX-6 Blocking Peptide, SSX 6 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- SSX6 (Synovial Sarcoma, X Breakpoint 6 (Pseudogene) (SSX6))
-
Sujet
- SSX6 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy.
-
Poids moléculaire
- 22 kDa
Antigène
-
Vous êtes ici:
